Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 4:02 pm Sale | 2023-05-31 | 13G | Core Laboratories N.V. CLB | ALGER ASSOCIATES INC | 0 0.000% | -3,853,977 (Position Closed) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Core Laboratories N.V. CLB | ALGER ASSOCIATES INC | 3,853,977 8.300% | -165,258 (-4.11%) | Filing History |
| 2023-02-14 09:10 am Purchase | 2022-12-31 | 13G | Core Laboratories N.V. CLB | Ariel Investments, LLC | 9,703,122 20.900% | 1,898,815 (+24.33%) | Filing History |
| 2023-02-14 08:32 am Purchase | 2022-12-31 | 13G | Core Laboratories N.V. CLB | EARNEST PARTNERS LLC | 3,573,101 7.700% | 139,671 (+4.07%) | Filing History |
| 2023-02-09 11:15 am Purchase | 2022-12-30 | 13G | Core Laboratories N.V. CLB | The Vanguard Group | 5,262,192 11.350% | 295,066 (+5.94%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 5,848,677 12.600% | 0 (Unchanged) | Filing |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 5,848,677 12.600% | 485,784 (+9.06%) | Filing |
| 2022-02-14 08:41 am Purchase | 2021-12-31 | 13G | Core Laboratories N.V. CLB | Ariel Investments, LLC | 7,804,307 16.900% | 634,890 (+8.86%) | Filing History |
| 2022-02-11 08:38 am Sale | 2021-12-31 | 13G | Core Laboratories N.V. CLB | EARNEST PARTNERS LLC | 3,433,430 7.400% | -833,318 (-19.53%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Core Laboratories N.V. CLB | The Vanguard Group | 4,967,126 10.730% | 383,866 (+8.38%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 5,362,893 11.600% | 0 (Unchanged) | Filing |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | Core Laboratories N.V. CLB | BlackRock Inc. BLK | 5,362,893 11.600% | 745,528 (+16.15%) | Filing |
| 2022-01-10 4:03 pm Sale | 2021-12-31 | 13G | Core Laboratories N.V. CLB | ALGER ASSOCIATES INC | 4,019,235 8.700% | -2,491,997 (-38.27%) | Filing History |
| 2022-01-04 3:32 pm Sale | 2022-01-04 | 13G | Core Laboratories N.V. CLB | Massachusetts Financial Services Company | 0 0.000% | -2,985,320 (Position Closed) | Filing History |
| 2021-12-10 1:49 pm Purchase | 2021-11-30 | 13G | Core Laboratories N.V. CLB | Ariel Investments, LLC | 7,169,417 15.500% | 2,648,416 (+58.58%) | Filing History |
| 2021-06-10 4:15 pm Purchase | 2021-05-31 | 13G | Core Laboratories N.V. CLB | ALGER ASSOCIATES INC | 6,511,232 14.060% | 4,147,086 (+175.42%) | Filing History |
| 2021-02-16 4:44 pm Purchase | 2020-12-31 | 13G | Core Laboratories N.V. CLB | ALGER ASSOCIATES INC | 2,364,146 5.310% | 2,364,146 (New Position) | Filing History |
| 2021-02-16 3:29 pm Purchase | 2020-12-31 | 13G | Core Laboratories N.V. CLB | EARNEST PARTNERS LLC | 4,266,748 9.600% | 1,332,632 (+45.42%) | Filing History |
| 2021-02-12 09:52 am Sale | 2020-12-31 | 13G | Core Laboratories N.V. CLB | Ariel Investments, LLC | 4,521,001 10.200% | -52,700 (-1.15%) | Filing History |
| 2021-02-11 3:13 pm Sale | 2021-02-11 | 13G | Core Laboratories N.V. CLB | Massachusetts Financial Services Company | 2,985,320 6.700% | -1,770,486 (-37.23%) | Filing History |